Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
Olga A. Khomich, Alexander V. Ivanov, Birke Bartosch
Cells (2019) Vol. 9, Iss. 1, pp. 24-24
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

NAFLD: Mechanisms, Treatments, and Biomarkers
Fatiha Nassir
Biomolecules (2022) Vol. 12, Iss. 6, pp. 824-824
Open Access | Times Cited: 241
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis
Santosh Kumar, Qihua Duan, Rongxue Wu, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113869-113869
Closed Access | Times Cited: 210
Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease
Xiaoqin Wu, Xiude Fan, Tatsunori Miyata, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 411-438
Open Access | Times Cited: 136
Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism
Zilong Zhang, Jin Shang, Qinyan Yang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome
Yang Xiao, Chong Zhao, Yang Tai, et al.
Redox Biology (2023) Vol. 62, pp. 102691-102691
Open Access | Times Cited: 62
The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms
Yuling Wang, Linke Jiao, Caoxia Qiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116116-116116
Open Access | Times Cited: 26
The m6A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis
Yongqiang Zhou, Jiexi Yan, He Huang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 17
Lactucin alleviates liver fibrosis by regulating the TLR4-MyD88-MAPK/NF-κB signaling pathway through intestinal flora
Liping Zhu, Bo Lv, Yuefeng Gao, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110341-110341
Closed Access | Times Cited: 1
Microenvironmental regulation of cancer cell metabolism: implications for experimental design and translational studies
Alexander Muir, Laura V. Danai, Matthew G. Vander Heiden
Disease Models & Mechanisms (2018) Vol. 11, Iss. 8
Open Access | Times Cited: 111
Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease
Jin Wang, Wanping He, Ping-Ju Tsai, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 111
The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD/CCL4-induced murine model of liver injury
Shahrbanoo Keshavarz Azizi Raftar, Fatemeh Ashrafian, Sara Abdollahiyan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 63
Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
Yufei Yan, Jiefei Zeng, Linhao Xing, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1014-1014
Open Access | Times Cited: 59
Rebalancing TGF‐β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis
Yang Yang, Mayu Sun, Weida Li, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 7
Open Access | Times Cited: 58
Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases
Raja Gopal Reddy Mooli, Dhanunjay Mukhi, Sadeesh K. Ramakrishnan
Comprehensive physiology (2022), pp. 3167-3192
Open Access | Times Cited: 44
Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases
Yannan Zheng, Rui Zhou, Jianan Cai, et al.
Cancer Research (2023) Vol. 83, Iss. 21, pp. 3577-3592
Open Access | Times Cited: 22
Kaempferol attenuates carbon tetrachloride (CCl4)-induced hepatic fibrosis by promoting ASIC1a degradation and suppression of the ASIC1a-mediated ERS
Rui Cao, Chun Cao, Xiaojie Hu, et al.
Phytomedicine (2023) Vol. 121, pp. 155125-155125
Closed Access | Times Cited: 22
Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
Yongyan Chen, Zhigang Tian
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 57-72
Open Access | Times Cited: 65
The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism
Nicole K.H. Yiew, Brian N. Finck
AJP Endocrinology and Metabolism (2022) Vol. 323, Iss. 1, pp. E33-E52
Open Access | Times Cited: 36
Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation
Rafał Frankowski, Mateusz Kobierecki, Andrzej Wittczak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9677-9677
Open Access | Times Cited: 19
Reprogramming of tissue metabolism during cancer metastasis
Koelina Ganguly, Alec C. Kimmelman
Trends in cancer (2023) Vol. 9, Iss. 6, pp. 461-471
Open Access | Times Cited: 17
Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling
Arezou Azizsoltani, Behzad Hatami, Mohammad Reza Zali, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115777-115777
Open Access | Times Cited: 16
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma
Yuan-dong Sun, Hao Zhang, Yuanmin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189086-189086
Closed Access | Times Cited: 7
Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?
Aneta Sokal, Sara Jarmakiewicz-Czaja, Katarzyna Ferenc, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5238-5238
Open Access | Times Cited: 6
Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?
Simon H. Bridge, Sabrina Pagano, John K. Lodge, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hepatic stellate cells role in the course of metabolic disorders development – A molecular overview
Nabila Bourebaba, Krzysztof Marycz
Pharmacological Research (2021) Vol. 170, pp. 105739-105739
Closed Access | Times Cited: 38
Page 1 - Next Page

Scroll to top